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Abstract 
BACKGROUND: Triad of childhood vesicoureteral reflux (VUR), urinary infection (UTI) and renal scarring might 
initiate potentially serious consequences that lead to renal dysfunction manifested at the second or third decade 
of life. 
AIM: To identify the risk factors predictive for renal dysfunction in adults with primary VUR after long-term follow-
up.  
METHODS: We evaluated the records of 101 children (94.1% female, 5.9% male) at a median age of 5.2 ± 2.3 
years (1-12 years), suffering from UTI and VUR. The patients were interviewed after mean 21 years from the first 
episodes of VUR (8 to 32 years). Renal function was determined from the estimated glomerular filtration rate 
(eGFR). 
RESULTS: Renal scarring was detected in 68.3% out of 82 patients and bilateral one in 7.3% patients. Linear 
regression analysis revealed that presence of proteinuria (B = -33.7, p=0.0001), the greater number of years from 
VUR diagnosis (B = -1.6, p = 0.002) and renal scarring (B = -14.8, p = 0.005) appeared as independent predictors 
of reduced global eGFRcreat. The same variables plus microalbuminuria (B = -1.0, p = 0.012) appeared as 
independent predictors of reduced global eGFRcreat-cys. Bilateral scarring (OR=25.5, p = 0.003) appeared as 
independent predictor of greater risk for CKD assessed using eGFRcreat while greater number of years from VUR 
diagnosis (OR = 1.7, p = 0.092), microalbuminuria (OR = 1.3, p = 0.047) and again bilateral scarring (OR = 31.3, 
p = 0.040) appeared as predictors of risk for CKD assessed using eGFRcreat-cys.  
CONCLUSION: Identification of those with an increased risk of progression to CKD should be the goal in all 
patients with childhood VUR. Their systematic follow-up should be till adulthood and older age. 
 
 
 
 
 
 
 
Introduction 
 
Primary vesicoureteral reflux (VUR) is a 
congenital urinary tract anomaly manifested by either 
a unilateral or bilateral reflux of urine from the bladder 
to the kidney which is diagnosed mostly after an 
episode of urinary tract infection (UTI) [1], [2]. The 
incidence of VUR is hard to establish but 
approximately affects 1-2% of children [3], and is 
much higher among children with UTI (15-70%, 
depending on age) [4]. The association between VUR 
and UTI with potentially serious consequences that 
ultimately lead to reflux nephropathy and renal 
dysfunction and/or failure in children is well 
established, from both clinical and experimental 
studies [5], [6], [7], [8]. Also, the association between 
VUR and the renal scarring has been confirmed in 
numerous published studies, and predictive risk 
factors for its occurrence have been established [8], 
[9], [10], [11], [12], [13], [14].
 
Furthermore, despite 
many advances have been made over the past 
decades in understanding the childhood VUR, its 
relations to UTI and prognosis as well as its choice of 
treatment, there have been still conflicting reports on 
the risk factors for worsening renal function in adult 
patients who were treated for childhood VUR.  
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Thus, the present study aimed to evaluate the 
renal function and to identify the predictors of its 
dysfunction in a cohort of patients with childhood VUR 
who were assessed after long-term follow-up. 
 
 
Methods  
 
We evaluated the records of 101 children of 
both sexes, aged between one and 12 years, suffering 
from UTI and primary VUR. According to the 
availability at that time, VUR was diagnosed with 
direct radionuclide cystography (RNC) at the Institute 
of pathophysiology and nuclear medicine in the 
presence of pediatric nephrologist and the specialised 
nurse from University Children’ Hospital. Patients with 
VUR associated with posterior urethral valves, ectopic 
ureterocele, neurogenic bladder, and other obstructive 
uropathies below bladder were excluded from the 
study.  
The following clinical variables were obtained 
from patient record: gender, the age of diagnosis of 
primary VUR (years), grade of primary VUR, unilateral 
or bilateral primary VUR, history of UTI, treatment 
modality (medical, surgical or endoscopic). VUR was 
graded according to International Reflux Study 
Committee into five grades [1], [15], [16].
 
Renal 
scarring was detected with technetium-99 m labelled 
dimercaptosuccinic acid (DMSA) renal scintigraphy, 
which was performed within 6 months of UTI [17].  
The patients were interviewed after 20,75± 
6,46 years from the first episodes of VUR (minimum 8 
to maximum 32 years). At the office visit, clinical 
history was taken. On physical examination weight 
and height as well as blood pressure were measured 
(systolic and diastolic). Also, blood and urine samples 
were collected for further analysis (concentration of 
creatinine and cystatin C in serum, albumin in urine 
and proteinuria using a dipstick) and ultrasonographic 
examination (measurements) of kidneys (Siemens 
Acusson S3000) was done. Creatinine clearance 
(CrCl) was calculated according to the Cockcroft-
Gault Equation [18]. According to the recommendation 
of Kidney Disease Improving Global Outcomes 
(KDIGO) [19] renal function was determined from the 
estimated glomerular filtration rate (eGFR) using the 
CKD-EPI Creatinine Equation (2009) for eGFRcreat 
and 2012 CKD-EPI creatinine-cystatin C equation for 
eGFRcreat-cyst. In accordance with this 
recommendation [19]
 
eGFR was categorized into 5 
categories as follows: G1-normal or high (≥ 90 
ml/min/1.73 m
2
), G2-mildly decreased (60-89 
ml/min/1.73 m
2 
), G3a-mildly to moderately decreased 
(45-59 ml/min/1.73 m
2 
), G3b-moderately to severely 
decreased (30-44 ml/min/1.73 m
2 
), G4-severely 
decreased (15-29 ml/min/1.73 m
2 
) and G5-kidney 
failure (< 15 ml/min/1.73 m
2 
). Thus patients were 
stratified by eGFR into groups. Chronic kidney 
disease (CKD) was confirmed if eGFRcreat and/or 
eGFRcreat-cyst was < 60 ml/min/1.73 m
2 
[19]. 
 
Statistical analysis 
Categorical parameters were summarised as 
percentages and continuous parameters as mean ± 
SD. Comparisons between groups were performed 
using Student-t-test and ANOVA analysis of variance 
with Bonferroni post-hoc analysis for continuous 
parameters and Pearson’s chi-square test for 
categorical parameters. Assessment of correlation of 
various echorenographic parameters was done using 
Pearson’s correlation analysis. Multiple linear and 
logistic regression analyses were performed to 
determine independent predictors of reduced eGFR 
and/or CKD presence, respectively. The area under 
the receiver operating characteristics (ROC) curve 
(AUC) was performed to quantify the value of 
independent predictors in discrimination of patients 
with and without CKD. All data analysis was 
performed using SPSS version 25.0 (IBM SPSS, Inc., 
Chicago, Illinois) and p-value ≤ 0.05 was considered 
significant. 
 
 
Results 
 
The baseline characteristics of patients are 
summarised in Table 1. A total of 101 patients 
diagnosed with primary VUR were recruited, of which 
95/94.1% were female and 6/5,9% male. The median 
age at VUR diagnosis was 5.2± 2.3 years. VUR was 
diagnosed at one year in 2 patients, at two years in 10 
patients, at 3 years in 9 patients, at 4 years in 19 
patients, at 5 years in 12 patients, at 6 years in 18 
patients, at 7 years in 16 patients, at 8 years in 9 
patients, at 10 years in 2 patients, at 11 years in 3 
patients and at 12 years in one patient. In all patients 
fever and UTI was present before VUR diagnosis was 
established. VUR was diagnosed at right kidney in 63 
patients and left kidney in 74 patients. Among patients 
with unilateral VUR, 48/76.2% had low-grade VUR 
(i.e. I–III) at right kidney and 61/82.4% at left kidney, 
while high-grade VUR (i.e. IV–V) was present in 
15/23.8% patients at right kidney and 13/17.6% 
patients at left kidney. Among those with bilateral 
VUR, 37 had a low-grade VUR, and 49 had a high-
grade VUR. Most patients (94.0%) were administrated 
prophylactic antibiotics, and the rest of all (7.0%) have 
STING (subureteral Teflon injection) procedure. In 
one patient nephrectomy of the right kidney was done. 
Of the 101 patients, 82 had a record of 
undergoing a DMSA within the time of VUR diagnosis. 
Considering both the right and left kidney, renal 
scarring was detected in 56/68.3% out of 82 patients 
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and bilateral one in 6/7.3% patients (Table 1). 
Table 1: Baseline characteristics of patients 
Parameters Numbers (%) 
Gender (n/%) 
Female 
Male 
 
95/94.1 
6/5.9 
Age at onset of VUR (years) 
Mean 
Range 
1-2 years (n/%) 
2-5 years (n/%) 
> 5 years (n/%) 
 
5.2 2.3 
1 to 12 
12/11.9 
40/39.6 
49/48.5 
UTI (n/%) 101/100 
Treatment  
Antibiotics 
STING 
Nephrectomy 
 
94/94.0 
7/7.0 
1/0.9 
VUR grade Right kidney (n = 63) Left kidney (n = 74) 
2.89 0.80 2.70 0.75 
Grade II (n/%) 23/36.5 35/47,3 
Grade III (n/%) 25/39.7 26/35,1 
Grade IV (n/%) 14/22.2 13/17,6 
Grade V (n/%) 1/1.6 - 
Bilateral VUR* (n/%) 37/37 
Renal scaring** (n/%) 56/68.3 
Bilateral scaring** 6/7.3 
* For 100 patients; ** For 82 patients; VUR = vesicoureteral reflux; STING = subureteral 
teflon injection 
 
After mean 20.8± 6.5 years from the first 
episode of VUR (8 to 32 years), laboratory analysis 
(serum, urine and ultrasound) were done. Patients 
who were 26.1± 4.9 of age (17 to 36 years) were 
divided according to the value of eGFRcreat into 3 
categories of renal dysfunction and compared 
regarding characteristics considered of importance for 
renal function. Due to the small number of patients, 
3Ga and 3Gb were considered as one group. Out of 
all, 67/66.3% were with normal renal function (G1), 
27/26.7% were with mildly decreased (G2), and 
7/6.9% were with moderately decreased (G3) renal 
function. The results of the comparison are shown in 
Table 2.  
A comparison of the characteristics among 
patients stratified according to the eGFRcreat (Table 
2) revealed that those with moderately impaired renal 
function in comparison to those with normal function 
were older, diagnosed with VUR at a younger age 
with significantly more years passed by after VUR was 
diagnosed, had a more serious grade of VUR 
(especially for left kidney) along with more frequently 
bilateral one. Of note was that renal scarrings were 
significantly more frequently present in the same 
patients’ group while bilateral one was significantly 
absent in patients with normal renal function in 
comparison to those with some grade of dysfunction. 
Blood pressure measurements didn’t show any 
difference between the groups. Furthermore, patients 
with mildly and moderately impaired renal function 
compared to those that had normal function showed a 
significantly lower value of CrCl. Those with 
moderately impaired renal function also showed 
ultrasonographical measured the significantly smaller 
size of both kidneys, a higher percentage of 
proteinuria as well as the higher value of albuminuria 
in comparison to those with normal function (Table 2). 
When the same comparison was made according to 
the value of eGFRcreat-cys, we obtained almost 
identical results. 
Table 2: Comparison of clinical and laboratory finding in adult 
patients who were diagnosed with childhood VUR divided 
according to the categories of eGFRcreat 
 eGFRcreat (ml/min/1.73 m
2
) p 
Characteristics G1 = 90 
(n = 67) 
G2 = 60-89 
(n = 27) 
G3 = 30-59 
(n = 7) 
Age (years) 24.8  5.0 28.5  3.5 29.0  4.3 0.001 
Gender (%) 
male 
female 
 
6/9.0 
61/91.0 
 
0 
27/100 
 
0 
7/100 
 
P = 0.197 
Age of VUR diagnosis 
(years) 
5.1  2.4 5.8  2.2 4.5  1.4 0.293 
Time from the first 
episode of VUR (years) 
19.6  4.5 22.6  4.0 24.4  3.6 0.001 
VUR grade/right kidney (n = 40) 
2.7  0.7 
(n = 17) 
3.1  0.9 
(n = 6) 
3.0  0.8 
0.324 
VUR grade/left kidney (n = 48) 
2.5  0.6 
(n = 21) 
2.9  0.8 
(n = 5) 
3.4  0.8 
0.008 
VUR bilateral 
no  
yes 
 
44/66.7 
22/33.3 
 
16/59.3 
11/40.7 
 
3/42.9 
4/57.1 
 
0.415 
Treatment(%) 
antibiotics 
STING 
 
64/95.5 
3/ 4.5 
 
23/85.2 
4/14.8 
 
7/100 
0 
0.173 
Scarring (%) (n=82) 
no  
yes 
 
22/40.7 
32/59.3 
 
3/14.3 
18/85.7 
 
1/14.3 
6/85.7 
0.051 
Bilateral scarring (%) 
(n=82) 
no 
yes 
 
 
51/94.4 
1/50.0 
 
 
21/100 
0 
 
 
4/57.1 
3/42.9 
 
0.001 
BPs (mmHg) 115.9  9.4 116.6  8.1 113.8  11.6 0.772 
BPd (mmHg) 76.9  6.0 77.7  4.5 77.8  4.0 0.765 
Right kidney (mm) 84.5  14.4 91.3  11.9 76.4  16.3 0.022 
Left kidney (mm) 84.0  16.2 89.4  13.0 72.1  14.2 0.027 
CrCl (ml/min) 118.9  26.9 77.9  12.6 55.2  14.4 0.0001 
Proteinuria (n/%) 
no 
yes 
 
64/95.5 
3/4.5 
 
23/85.2 
4/14.8 
 
0 
7/100 
0.0001 
Albuminuria (mg/L) 11.2  4.2 13.6  6.2 14.4  1.5 0.038 
eGFRcreat = glomerular filtration rate according serum creatinine concentration; VUR = 
vesicoureteral reflux; STING = subureteral teflon injection; BPs = blood pressure in 
systole; BPd = blood pressure in diastole; CrCl = creatinin clearence. 
 
In addition, correlation of either eGFRcreat or 
eGFRcreat-cys with parameters that were related 
revealed significant relation between lower eGFRcreat 
or eGFRcreat-cys and longer time since VUR 
diagnosis (r = -0.450, p = 0.0001; r = -0.445, p = 
0.0001; respectively), higher grade of primary 
unilateral VUR (r = -0.352, p = 0.002; r = -0.324, p = 
0.005; respectively), presence of unilateral renal 
scarring (r = -0.244, p = 0.027; r = -0.294, p = 0.007; 
respectively) and bilateral ones (r = -0.307, p = 0.005; 
r = -0.329, p = 0.003; respectively) as well as 
presence of proteinuria (r = -0.486, p = 0.0001; r = -
0.463, p = 0.0001; respectively) and greater level of 
albuminuria (r = -0.251, p = 0.012; r = -0.307, p = 
0.002; respectively). 
 
Predictive variables of reduced eGFR 
To determine the independent predictors of 
reduced eGFR among patients with childhood VUR, 
we performed multiple stepwise linear regression 
analysis with covariates that showed a significant 
relation to it. The results demonstrated that the 
presence of proteinuria, the greater number of years 
since from VUR diagnosis and the presence of renal 
scarring appeared as independent predictors of 
reduced global eGFR assessed according to serum 
creatinine value (eGFRcreat) (Model 1, Table 3, 
Figure 1). Microalbuminuria (B = −0.159, p = 0.117), 
bilateral renal scarring (−0.088, p = 0.382) and VUR 
grade of left kidney (B = −0.082, p = 0.434) were 
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excluded as non-predictive variables in the regression 
analysis. When we used eGFR assessed according to 
serum creatinine and cystatin C values (eGFRcreat-
cys) the results demonstrated that the presence of 
proteinuria, value of microalbuminuria, the greater 
number of years since VUR diagnosis and the 
presence of renal scarring appeared as independent 
predictors of reduced global eGFRcreat-cys (Model 2, 
Table 3, Figure 1).  
Table 3: Multiple linear or logistic regression models of eGFR 
as the dependent variable and its independent predictors 
Linear regression B Beta Sig. 95%CI 
Model 1 
Proteinuria -33.783 -0.481 0.0001 (-47.387)-(-20.178) 
Years VUR dgn -1.651 -0.307 0.002 (-2.675) – (-0.628) 
Renal scarring -14.835 -0.274 0.005 (-24.973)-(-4.697) 
Model 2 
Proteinuria -33.031 0.522 0.0001 (-44.540)-(-21.521) 
Years VUR dgn -1.177 -0.243 0.005 (-1.991)-(-0.364) 
Microalbuminuria -1.027 -0.230 0.012 (-1.821)-(-0.233) 
Renal scarring -9.888 -0.203 0.018 (-18.032)-(-1.744) 
Logistic 
regression 
Exp(B) Wald Sig. 95%CI 
Model 3 
Bilateral scarring 25.500 8.842 0.003 3.016-215.594 
Model 4 
Years VUR dgn 1.769 3.998 0.092 0.911-3.436 
Microalbuminuria 1.333 3.946 0.047 1.004-1.771 
Bilateral scarring 31.304 4.233 0.040 1.177-832.313 
Model 1: linear regression analysis with eGFRcreat as dependent variable; Model 2: linear 
regression analysis with eGFRcreat-cys as dependent variable; Model 3: logistic 
regression analysis with eGFRcreat with and without value of < 60 ml/min/1.73 m
2
 as 
dependent variable. Model 4: logistic regression analysis with eGFRcreat-cys with and 
without value of < 60 ml/min/1.73 m
2
 as dependent variable; CI = confidence interval; VUR 
= vesicoureteral reflux; Dgn = diagnosis. 
 
Again bilateral renal scarring (−0.086, p = 
0.330) and VUR grade of left kidney (B = −0.030, p = 
0.742) were excluded as non-predictive variables in 
the regression analysis. To confirm the role of the 
same variables in the prediction of the presence of 
CKD (< 60 ml/min/1.73 m
2
) we performed a logistic 
regression analysis using almost the same variables 
(proteinuria was excluded as an indisputable 
significant predictor) as independent predictors.  
 
Figure 1: Scatter plot of standardised residual vs standardised 
predicted value with a regression line for eGFRcreat (left) and 
eGFRcreat-cys (right) 
 
The results showed that only presence of 
bilateral scarring appeared as an independent 
predictor of risk for CKD (Model 3, Table 3) assessed 
using eGFRcreat. Years of VUR diagnosis (2,206, p = 
0.137), VUR grade of left kidney (0.780, p = 0.337), 
microalbuminuria (0.106, p = 0.745) and renal scarring 
(0.161, p = 0.281) were excluded as non-predictive 
variables in the regression analysis. When we used 
eGFRcreat-cys, the greater number of years since 
VUR diagnosis, the value of microalbuminuria and 
presence of bilateral scarring appeared as predictors 
of risk for CKD (Model 4, Table 3). VUR grade of left 
kidney (2.798, p = 0.094) and renal scarring (0.578, p 
= 0.447) were excluded as non-predictive variables in 
the regression analysis. 
In order to confirm the role of independent 
predictors in discrimination of patients with and 
without CKD assessed using eGFRcreat-cys, ROC 
analysis (Figure 2) revealed that addition of 
microalbuminuria to bilateral scarring (AUC=0.667, 
95% CI: 0.435-0.899, p = 0.123) and greater years 
since diagnosis VUR (AUC = 0.789, 95% CI: 0.660-
0.919, p = 0.007) significantly improved the AUC 
(AUC = 0.809, 95% CI: 0.657–0.962, p = 0.004). Also, 
we determined 21.5 years since VUR diagnosis as a 
cut-off value with the highest sensitivity of 87.5% and 
a specificity of 57.5% for determining the existence of 
CKD according to eGFRcreat- cys. 
 
Figure 2: ROC curve for the presence of chronic kidney disease 
assessed using eGFRcreat-cys 
  
 
 
Discussion 
 
In the present study, a total of 101 patients 
were diagnosed with primary VUR at a median age of 
5 years. Among patients with unilateral VUR, low-
grade VUR (i.e. I–III) was present in over 70% of 
patients while high-grade VUR (i.e. IV–V) was present 
in 23.8% patients at right kidney and 17.6% patients 
at left kidney. Considering both the right and left 
kidney, renal scarring was detected in 56/68.3% out of 
82 patients and bilateral one in 6/7.3% patients. 
As we already stressed an association 
between childhood VUR and the renal scarring had 
been confirmed in numerous published studies [8], [9], 
[10], [11], [12], [13], [14].
 
In the meta-analysis of 
Shaikh et al., [12] the prevalence of renal scarring was 
2.6 times (95% CI: 1.7–3.9) higher among children 
with VUR than among children without VUR (41% vs 
17%; P < 001). Prospective clinical studies showed 
that the risk of renal scarring after acute DMSA 
abnormalities detected at acute febrile UTI is 
significantly greater in patients with high-grade VUR, 
affecting up to 89% with grade IV–V VUR [8], [20], 
[21]. In the meta-analysis of 27 clinical studies, Faust 
et al., [11] demonstrated an increased risk of acquired 
renal scarring in children with VUR vs without VUR 
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(OR 2.8 and 3.7, respectively). 
Hence, the prevalence of renal scarring has 
been reported to be in the range from 15-62%.
 
Bailey 
et al., [22] showed that after a mean of 24 years of 
follow-up out of 21 patients only 4/19% had normal 
kidneys, although the study included only those with 
gross childhood VUR. Also, Olbing et al., [23] in a 
prospective trial of 223 patients with severe VUR who 
were followed-up for 10 years showed unscarred 
kidneys on urography only in 38% of these children. 
Smellie et al., [24] found scars in 44% of their patients 
with severe VUR that were a follow-up for 10-41 
years. Also, Vasama-Lahdes et al., in the study of 127 
patients treated for non-obstructive VUR of any grade 
with the mean age of 41 years documented presence 
of unilateral scarring in 35% and bilateral one in 24% 
of subjects assessed by ultrasound. 
Furthermore, Swerkersson et al., [8] in their 
retrospective analysis of 303 children younger than 2 
years with a culture verified UTI and VUR in 22% of 
them, reported 26% permanent renal damage 
according to DMSA scintigraphy. Recently, among 
958 patients studied by Madani et al., [25] DMSA scan 
showed renal damage in 41.2% of patients. Almost all 
published data found a strong association between 
severity of VUR and renal scarring. However, our 
study showed a higher percentage of renal scarring 
which was in line with the study of Abeysekara et al., 
[26] and Macedo et al., [27] who detected renal 
scarring among patients with primary VUR in 55.3% 
and 55.2% of them, respectively. The higher 
percentages probably should be explained by 
ineffective treatment of UTI and VUR in that period 
when patients were diagnosed along with the fact that 
patients might have had multiple febrile UTIs before 
their first cystography. Furthermore, the higher 
percentage of renal scarring was also found when 
DMSA scan was used instead of ultrasound for 
detection.  
Given that renal scarring was recognised as a 
predictive factor for an increased risk of renal 
dysfunction that may not be present until the second 
or third decade of life, it was of great importance to 
conduct our study to confirm such findings [1]. Thus, 
in our study of patients with unilateral or bilateral 
childhood primary VUR it was found that patients with 
moderately impaired renal function in comparison to 
those with normal function stratified according to the 
eGFRcreat or eGFRcreat-cys were older, diagnosed 
with VUR at a younger age with significantly more 
years passed by after VUR was diagnosed, had a 
more serious grade of VUR (especially for left kidney) 
along with more frequently bilateral one. Also, renal 
scarring was more frequently present in patients with 
renal dysfunction while bilateral one was significantly 
absent in patients with normal renal function in 
comparison to those with some grade of dysfunction. 
As for predictors of renal dysfunction regression 
analysis revealed that presence of proteinuria, the 
greater number of years since VUR diagnosis and the 
presence of renal scarring appeared as independent 
predictors of reduced global eGFRcreat while the 
same variables plus microalbuminuria appeared as 
independent predictors of reduced global eGFRcreat-
cys. Furthermore, presence of bilateral scarring 
appeared as an independent predictor of greater risk 
for CKD assessed using eGFRcreat while a greater 
number of years since VUR diagnosis, the value of 
microalbuminuria and again the presence of bilateral 
scarring appeared as predictors of risk for CKD 
assessed using eGFRcreat-cys.  
Our results were in general in line with those 
from literature. Several studies have focused on risk 
factors for developing renal dysfunction and/or CKD in 
patients with childhood VUR. Ardissino et al., [28] in 
the epidemiological study conducted in Italy (i.e. 
ItalKid Project), documented that VUR was found to 
be the single leading cause of CKD in children, 
accounting for 25.8% of cases. When the population 
was subdivided according to the creatinine clearance 
(Ccr) levels, patients with VUR and Ccr < 25 
mL/min/1.73 m
2 had an overall risk of 68% for 
progressing to end-stage renal disease (ESRD) by the 
age of 20. In the study of El-Khatib et al., [29] 147 
patients with reflux nephropathy and/or primary VUR 
were followed for two years or more (range 2-19 
years) and deterioration in renal function was 
documented in 37% of them; the identified risk factors 
were the presence of proteinuria, an elevated plasma 
creatinine concentration, bilateral scarring, male sex 
and the presence of hypertension. Nakashima et al., 
[30], followed 95 patients who had a renal scar or 
grade III or higher VUR and found that 35% 
demonstrated renal function deterioration; the 
identified risk factors were the presence of bilateral 
scarring, proteinuria > 300 mg per day, diastolic 
hypertension and low eGFR. In addition, Vasama-
Lahdes et al., [9] in 147 (55%) of 267 patients treated 
for childhood VUR found that eGFR was normal only 
in 33% of patients and those with bilateral scarring 
(3%) were significantly more likely to have reduced 
eGFR, while approximately 7% of patients with VUR 
progress to ESRD. Caione et al., [31] followed-up for 
1-16 years 50 patients with bilateral VUR and found 
CKD in 54% of them with significant risk for its 
development in those with bilateral high-grade VUR 
and serum creatinine levels > 6.0 mg/L in the first year 
of life. However, Silva et al., [32] determined that age 
at diagnosis > 24 months, VUR grade V, bilateral 
renal damage, and a delay in the diagnosis of VUR of 
> 12 months after UTI were independent predictors of 
CKD. In addition, North American Pediatric Renal 
Trials and Collaborative Studies (NAPRTCS) Registry 
found that in only 8.5% of patients VUR was the 
cause of CKD whereas Novak et al., [33] on data from 
the NAPRTCS suggested that older age, higher CKD 
stage, and history of UTI are significant risk factors for 
CKD progression in children with VUR. Furthermore, 
Chen at al., [34] recruited total of 173 patients with 
primary VUR and found that older age of VUR 
diagnosis (≥ 5 years vs < 1 year), higher grade of 
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VUR and higher number of UTI were risk factors for 
renal scarring, whereas a younger age of VUR 
diagnosis, renal scarring and acute pyelonephritis 
were risk factors for developing CKD stage two or 
higher.  
Study limitations: The main limitation of our 
study was a relatively small number of patients. Also, 
the number of repetitive UTI during a follow-up period 
was not documented. We didn’t analyse either 
biochemical parameters of renal function in the 
childhood or the aetiology of infection. 
In conclusion, in adult patients who were 
treated for childhood VUR, the presence of 
proteinuria, the greater number of years since VUR 
diagnosis and renal scarring appeared as 
independent predictors of reduced global eGFRcreat 
along with microalbuminuria for reduced eGFRcreat-
cys. Bilateral scarring appeared as an independent 
predictor of greater risk for CKD assessed either using 
eGFRcreat or eGFRcreat-cys. 
A better understanding of the risk factors for 
renal scarring, and deteriorating renal function can be 
useful in tailoring the management and therapeutic 
approach for VUR. Additionally, identification of those 
with an increased risk of progression to CKD should 
be the goal in all patients with childhood VUR. Their 
systematic follow-up should be till adulthood and 
further to an older age.  
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